Eisai

Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Mon, 12/23/19 - 11:36 pm
Eisai
Purdue
FDA
drug launches
insomnia
Dayvigo
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Mon, 09/30/19 - 12:06 pm
Dova Pharmaceuticals
Eisai
Swedish Orphan Biovitrum
M&A
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Wed, 09/18/19 - 09:56 am
Merck
Keytruda
Eisai
Lenvima
endometrial cancer
Canada
Australia
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Eisai launches first startup incubator under its genomics center for dementia
Fierce Biotech
Tue, 07/9/19 - 11:53 am
Eisai
incubators
Cambridge
genomics
dementia
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Wed, 06/19/19 - 09:51 am
Schrödinger
R&D
Eisai
Merck
biotech
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Sat, 06/15/19 - 05:44 pm
Alzheimer's disease
drug development
Biogen
Eisai
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Alzheimer's disease
drug development
aducanumab
Biogen
Eisai
BAN2401
Merck
Eli Lilly
AstraZeneca
New Eisai venture arm to focus on digital tech, dementia, cancer
BioCentury
Fri, 05/10/19 - 06:02 pm
Eisai
venture capital
dementia
digital technology
cancer
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Sun, 05/5/19 - 10:36 am
Eisai
Biogen
Alzheimer's disease
R&D
aducanumab
BAN2401
After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug
NPR
Sat, 05/4/19 - 02:35 pm
Alzheimer's disease
R&D
drug development
beta amyloid
Biogen
Eisai
aducanumab
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Eisai
Purdue Pharma
insomnia
lemborexant
FDA
Is a severely damaged Biogen looking to shed its ties to a controversial development partner?
Endpoints
Sat, 03/23/19 - 12:07 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Biogen
Eisai
BAN2401
Alzheimer's disease
clinical trials
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Thu, 03/21/19 - 09:56 am
Biogen
Eisai
Alzheimer's disease
clinical trials
aducanumab
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Eisai
Takeda
GARDP
antibiotics
R&D
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Pharmaceutical Business Review
Mon, 12/10/18 - 01:15 pm
Eisai
Alzheimer's disease
E2814
clinical trials
University College London
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
Tue, 10/30/18 - 12:15 pm
FDA
drug reps
physicians
Eisai
Fycompa
drug marketing
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Biogen
Eisai
BAN2401
Alzheimer's disease

Pages